Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Apellis Pharmaceuticals Inc (NASDAQ: APLS) was $47.46 for the day, down -0.06% from the previous closing price of $47.49. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 1.11 million shares were traded. APLS stock price reached its highest trading level at $48.76 during the session, while it also had its lowest trading level at $47.22.
Ratios:
Our analysis of APLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.50 and its Current Ratio is at 3.10. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.54.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on February 05, 2024, Upgraded its rating to Buy and sets its target price to $80 from $68 previously.
On November 09, 2023, Goldman started tracking the stock assigning a Buy rating and target price of $74.Goldman initiated its Buy rating on November 09, 2023, with a $74 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 08 ’24 when Deschatelets Pascal sold 69,107 shares for $54.17 per share. The transaction valued at 3,743,605 led to the insider holds 1,115,983 shares of the business.
Sullivan Timothy Eugene sold 4,000 shares of APLS for $234,640 on Apr 01 ’24. The Chief Financial Officer now owns 93,338 shares after completing the transaction at $58.66 per share. On Mar 19 ’24, another insider, Dunlop A. Sinclair, who serves as the Director of the company, sold 18,681 shares for $57.18 each. As a result, the insider received 1,068,161 and left with 173,998 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 5756613120 and an Enterprise Value of 5478198784. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.43 while its Price-to-Book (P/B) ratio in mrq is 29.17. Its current Enterprise Value per Revenue stands at 13.813 whereas that against EBITDA is -10.63.
Stock Price History:
Over the past 52 weeks, APLS has reached a high of $94.75, while it has fallen to a 52-week low of $19.83. The 50-Day Moving Average of the stock is -15.70%, while the 200-Day Moving Average is calculated to be -7.06%.
Shares Statistics:
APLS traded an average of 1.42M shares per day over the past three months and 1815130 shares per day over the past ten days. A total of 119.56M shares are outstanding, with a floating share count of 98.84M. Insiders hold about 18.03% of the company’s shares, while institutions hold 91.57% stake in the company. Shares short for APLS as of 1713139200 were 10669213 with a Short Ratio of 7.51, compared to 1710460800 on 10591406. Therefore, it implies a Short% of Shares Outstanding of 10669213 and a Short% of Float of 12.16.
